HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Hau Selected Research

Amino Acids

12/2017AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.
1/2017Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
4/2015Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Hau Research Topics

Disease

55Glioma (Gliomas)
06/2022 - 09/2002
53Neoplasms (Cancer)
06/2022 - 03/2002
45Glioblastoma (Glioblastoma Multiforme)
08/2022 - 12/2003
14Brain Neoplasms (Brain Tumor)
06/2022 - 03/2002
8Medulloblastoma
11/2021 - 01/2008
6Neoplasm Metastasis (Metastasis)
04/2018 - 03/2002
5Melanoma (Melanoma, Malignant)
01/2013 - 03/2002
4Disease Progression
06/2015 - 09/2009
3Infections
08/2022 - 01/2008
3Astrocytoma (Pilocytic Astrocytoma)
06/2022 - 11/2009
3Meningioma (Meningiomas)
01/2020 - 01/2017
3Lymphoma (Lymphomas)
01/2020 - 02/2009
2COVID-19
08/2022 - 11/2021
2Oligodendroglioma
06/2022 - 11/2016
2Seizures (Absence Seizure)
01/2017 - 09/2016
2Hypertension (High Blood Pressure)
01/2017 - 03/2016
2Carcinoma (Carcinomatosis)
01/2013 - 01/2008
1Obesity
08/2022
1Vomiting
01/2022
1Ascorbic Acid Deficiency (Vitamin C Deficiency)
01/2022
1Nausea
01/2022
1Necrosis
01/2021
1Diabetes Mellitus
01/2020
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2020
1Pituitary Neoplasms (Pituitary Adenoma)
01/2020

Drug/Important Bio-Agent (IBA)

30Temozolomide (Temodar)FDA LinkGeneric
08/2022 - 03/2005
8Lomustine (CCNU)FDA Link
08/2022 - 01/2008
8Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2002
8Metformin (Glucophage)FDA LinkGeneric
01/2020 - 01/2016
7Transforming Growth Factor beta2IBA
10/2014 - 02/2006
6Bevacizumab (Avastin)FDA Link
08/2022 - 03/2016
6Pharmaceutical PreparationsIBA
01/2022 - 01/2008
5Irinotecan (Camptosar)FDA LinkGeneric
08/2022 - 10/2016
5Biological ProductsIBA
01/2020 - 09/2002
5Diclofenac (SR 38)FDA LinkGeneric
08/2018 - 01/2013
5Transforming Growth Factor beta (TGF-beta)IBA
10/2016 - 02/2006
5Lactic Acid (Lactate)FDA LinkGeneric
01/2015 - 08/2009
5TrabedersenIBA
12/2011 - 01/2005
5liposomal doxorubicin (Doxil)FDA Link
09/2009 - 09/2002
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022 - 12/2016
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 01/2015
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2013
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2004
4MethyltransferasesIBA
09/2019 - 10/2016
4Sunitinib (Sutent)FDA Link
01/2019 - 01/2014
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 01/2016
4Messenger RNA (mRNA)IBA
11/2009 - 03/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 10/2012
3ORALIT (ORS)IBA
01/2020 - 01/2016
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2019 - 03/2016
3Amino AcidsFDA Link
12/2017 - 04/2015
3Peptides (Polypeptides)IBA
10/2016 - 09/2002
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016 - 01/2013
3Tyrosine Kinase InhibitorsIBA
01/2016 - 01/2014
3Protein Isoforms (Isoforms)IBA
09/2015 - 12/2011
3Lactate Dehydrogenase 5IBA
02/2013 - 08/2009
2alpha-hydroxyglutarateIBA
04/2021 - 11/2020
2Vincristine (Oncovin)FDA LinkGeneric
05/2020 - 01/2008
2Analgesics (Analgesic Drugs)IBA
01/2018 - 01/2016
2Ibuprofen (Motrin)FDA LinkGeneric
01/2018 - 01/2015
2Tyrosine (L-Tyrosine)FDA Link
12/2017 - 04/2015
2(18F)fluoroethyltyrosineIBA
12/2017 - 01/2017
2Insulin (Novolin)FDA Link
01/2017 - 03/2016
2Valproic Acid (Depakote)FDA LinkGeneric
09/2016 - 03/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2016 - 01/2010
2Small Interfering RNA (siRNA)IBA
10/2014 - 08/2009
2Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2011 - 09/2002
2Antisense OligonucleotidesIBA
11/2009 - 01/2005
2EnzymesIBA
08/2009 - 01/2007
2Alkylating AgentsIBA
01/2007 - 03/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2007 - 03/2004
1Anti-Bacterial Agents (Antibiotics)IBA
08/2022
1SteroidsIBA
08/2022
1Protons (Proton)IBA
06/2022
1Meclofenamic Acid (Meclofenamate)FDA LinkGeneric
01/2022
1Dehydroascorbic AcidIBA
01/2022
1CollagenIBA
01/2022
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2022
1AntiemeticsIBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2021
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
11/2021
1Inositol (Myoinositol)IBA
11/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2020
1Cisplatin (Platino)FDA LinkGeneric
05/2020
1ParaffinIBA
01/2020

Therapy/Procedure

29Therapeutics
06/2022 - 09/2002
21Radiotherapy
08/2022 - 12/2003
15Drug Therapy (Chemotherapy)
01/2022 - 07/2008
9Chemoradiotherapy
05/2020 - 09/2014
3Aftercare (After-Treatment)
01/2017 - 01/2008
3Combined Modality Therapy
06/2015 - 05/2004
2Maintenance Chemotherapy
05/2020 - 03/2013
2Combination Drug Therapy (Combination Chemotherapy)
01/2018 - 02/2009
2Glycemic Control
01/2017 - 03/2016
2Salvage Therapy
07/2010 - 12/2003
1Artificial Respiration (Mechanical Ventilation)
08/2022
1Re-Irradiation
01/2022
1Conformal Radiotherapy
01/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021
1Electrodes (Electrode)
01/2021